Gain Therapeutics Ownership | Who Owns Gain Therapeutics?

Gain Therapeutics Ownership Summary

Gain Therapeutics is owned by 6.52% institutional investors, 2.29% insiders, and 91.20% retail investors. Marshall wace, llp is the largest institutional shareholder, holding 5.37% of GANX shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.01% of its assets in Gain Therapeutics shares.

GANX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Gain Therapeutics	6.52%	2.29%	91.20%
Sector	Healthcare Stocks	35.74%	11.83%	52.43%
Industry	Biotech Stocks	36.05%	11.82%	52.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Marshall wace, llp	1.77M	5.37%	$3.43M
Potomac capital management	1.01M	3.06%	$1.96M
Jones financial companies lllp	631.62K	1.92%	$1.16M
Hohimer wealth management	330.00K	1.84%	$422.40K
Cambridge investment research advisors	568.64K	1.72%	$1.10M
Dme capital management, lp	566.13K	1.72%	$1.10M
Vanguard group	569.90K	1.63%	$1.84M
Geode capital management	447.34K	1.36%	$868.53K
Susquehanna group, llp	431.27K	1.31%	$836.66K
Gsa capital partners llp	312.47K	0.95%	$606.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Potomac capital management	1.01M	1.70%	$1.96M
Hohimer wealth management	330.00K	0.10%	$422.40K
Gsa capital partners llp	312.47K	0.04%	$606.00K
Dme capital management, lp	566.13K	0.03%	$1.10M
Millington financial advisors	15.00K	0.01%	$29.25K
Two sigma securities	27.32K	0.01%	$48.36K
Benedict financial advisors	15.50K	0.01%	$30.07K
Oliver luxxe assets	20.25K	0.01%	$39.28K
Prelude capital management	35.82K	0.01%	$69.49K
Xtx topco	54.20K	0.01%	$95.94K

Top Buyers

Holder	Shares	% Assets	Change
Hohimer wealth management	330.00K	0.10%	330.00K
Gsa capital partners llp	312.47K	0.04%	292.00K
Vanguard fiduciary trust	229.98K	0.00%	229.98K
Ubs group	220.49K	0.00%	139.37K
Stratos wealth partners	131.62K	0.00%	131.62K

Top Sellers

Holder	Shares	% Assets	Change
Timelo investment management	-	-	-605.29K
Alyeska investment group	-	-	-450.00K
Raymond james & associates	-	-	-260.02K
Susquehanna group, llp	431.27K	0.00%	-253.08K
Gotham asset management	-	-	-245.90K

New Positions

Holder	Shares	% Assets	Change	Value
Hohimer wealth management	330.00K	0.10%	330.00K	$422.40K
Vanguard fiduciary trust	229.98K	0.00%	229.98K	$446.16K
Stratos wealth partners	131.62K	0.00%	131.62K	$255.34K
Xtx topco	54.20K	0.01%	54.20K	$95.94K
Schonfeld strategic advisors	24.50K	0.00%	24.50K	$47.53K

Sold Out

Holder	Change
Hm payson	-1.00K
State of wyoming	-1.44K
Fny investment advisers	-2.00K
Raymond james financial	-2.30K
Bnp paribas arbitrage, snc	-2.38K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	18	-65.38%	2,148,174	-73.34%	6	1.23%	11	-69.44%	2	-50.00%
Dec 31, 2025	32	-17.95%	5,557,142	28.00%	15	7.76%	24	4.35%	3	-25.00%
Sep 30, 2025	19	-44.12%	2,622,446	-26.12%	8	6.32%	10	-37.50%	2	-50.00%
Jun 30, 2025	36	2.86%	3,787,859	34.77%	12	13.00%	17	-22.73%	5	150.00%
Mar 31, 2025	35	29.63%	2,384,406	20.20%	8	14.87%	21	16.67%	3	50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	432.46K	1.01%	32.57K
Fidelity Extended Market Index	223.22K	0.52%	29.20K
BANOR SICAV Rosemary S EUR Acc	120.00K	0.31%	-1.59K
Extended Equity Market Fund E	119.89K	0.28%	77.97K
Extended Equity Market Fund B	119.89K	0.28%	77.97K
Blackrock Extended Mkt Fund CF	119.89K	0.28%	-
Extended Equity Market Fund K	102.08K	0.24%	-748.00
BlackRock Extended Equity Market Fund K	102.08K	0.24%	-748.00
iShares Micro-Cap ETF	96.11K	0.23%	-
BlackRock Extended Equity Market K	36.53K	0.14%	-16.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 09, 2024	Mack Gene	CFO and Interim CEO	Buy	$14.54K
Aug 09, 2024	Islam Khalid	Executive Chairman	Buy	$49.94K
Jul 01, 2024	RICHMAN ERIC I	-	Buy	$14.52K
Jul 01, 2024	RICHMAN ERIC I	-	Buy	$6.15K
Mar 28, 2024	Riley Jeffrey Scott	-	Buy	$115.77K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	4	-
2024 Q2	-	-

GANX Ownership FAQ

Who Owns Gain Therapeutics?

Gain Therapeutics shareholders are primarily institutional investors at 6.52%, followed by 2.29% insiders and 91.19% retail investors. The average institutional ownership in Gain Therapeutics's industry, Biotech Stocks , is 36.05%, which Gain Therapeutics falls below.

Who owns the most shares of Gain Therapeutics?

Gain Therapeutics’s largest shareholders are Marshall wace, llp (1.77M shares, 5.37%), Potomac capital management (1.01M shares, 3.06%), and Jones financial companies lllp (631.62K shares, 1.92%). Together, they hold 10.34% of Gain Therapeutics’s total shares outstanding.

Does Blackrock own Gain Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Gain Therapeutics.

Who is Gain Therapeutics’s biggest shareholder by percentage of total assets invested?

Potomac capital management is Gain Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.70% of its assets in 1.01M Gain Therapeutics shares, valued at 1.96M$.

Who is the top mutual fund holder of Gain Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Gain Therapeutics shares, with 1.01% of its total shares outstanding invested in 432.46K Gain Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools